Isoquinolin-1(2H)-ones and 1,6-naphthyridin-5(6H)-ones by an N-acylation-SNAr sequence
摘要:
A new synthesis of 2,3-dialkyl-4-carbomethoxyisoquinolin-1(2H)-ones and 6,7-dialky1-8-carbomethoxy1,6-naphthyridin-5(6H)-ones is reported. The process involves treatment of a beta-enaminoester with 2-fluoro-5-nitrobenzoyl chloride, 2-fluorobenzoyl chloride or 2-chloronicotinoyl chloride followed by heating in the presence of base. The conversion, which proceeds by an N-acylation-SNAr reaction sequence, affords 50-86% yields when R-1 is n-alkyl but <= 30% yields when R-1 is alpha-branched. (C) 2013 Elsevier Ltd. All rights reserved.
A highly stereoselective trichlorosilane-mediated reduction of N-benzyl enamines was developed; the combination of a low cost, easy to make metal-free catalyst and an inexpensive chiral auxiliary allowed to perform the reaction on substrates with different structural features often with total control of the stereoselectivity. By easy deprotection through hydrogenolysis followed by conversion of β-aminoester
[EN] N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER<br/>[FR] DERIVES D'ACIDE ACETIQUE N-BENZYLINDOLE-3 POUVANT ETRE UTILISES DANS LE TRAITEMENT DE CANCERS PHARMACORESISTANTS
申请人:UNIV DUBLIN CITY
公开号:WO2002020478A1
公开(公告)日:2002-03-14
A family of compounds, N-Benzylindoel-3-acetic acid derivatives, are active as inhibitors of multiple drug resistance protein (MRP) while having low direct toxicity, low COX -1 inhibitory activity and, in some cases, having useful activities such as COX-1 inhibition. The agents are useful in combination with MRP substrate drugs in the treatment of, for example, drug resistant cancer or tumours likely to develop drug resistant cancers because they can be given at higher concentration while being less toxic and having less side effects than known MRP inhibitors. The agents may also be more beneficial in the treatment of diseases which are dependent on MRP-1 activity or where MRP-1 activity reduces the effectiveness of existing therapies.
Isoquinolin-1(2H)-ones and 1,6-naphthyridin-5(6H)-ones by an N-acylation-SNAr sequence
作者:Richard A. Bunce、Baskar Nammalwar、Krishna Kumar Gnanasekaran、Nicholas R. Cain
DOI:10.1016/j.tet.2013.12.033
日期:2014.1
A new synthesis of 2,3-dialkyl-4-carbomethoxyisoquinolin-1(2H)-ones and 6,7-dialky1-8-carbomethoxy1,6-naphthyridin-5(6H)-ones is reported. The process involves treatment of a beta-enaminoester with 2-fluoro-5-nitrobenzoyl chloride, 2-fluorobenzoyl chloride or 2-chloronicotinoyl chloride followed by heating in the presence of base. The conversion, which proceeds by an N-acylation-SNAr reaction sequence, affords 50-86% yields when R-1 is n-alkyl but <= 30% yields when R-1 is alpha-branched. (C) 2013 Elsevier Ltd. All rights reserved.